NCT00749242

Brief Summary

This study will compare two treatments in acute stable traumatic vertebral fractures (types A1, A2 and A3.1 in MAGERL Classification). The two treatments are the followings:

  1. 1.Conservative Orthopedic Management consisting of brace and pain medication.
  2. 2.Percutaneous Balloon Kyphoplasty, a variant of Vertebroplasty, in which a balloon is first placed into the fractured vertebra and inflated with fluid in order to create a cavity. This may restore part of the vertebral height loss due to the fracture and facilitate the injection of the cement with low pressure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Dec 2007

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2007

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 8, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 9, 2008

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

December 16, 2014

Status Verified

November 1, 2012

Enrollment Period

4.5 years

First QC Date

September 8, 2008

Last Update Submit

December 13, 2014

Conditions

Keywords

Traumatic vertebral fractureVertebroplastyBalloon kyphoplastyBohler bracing

Outcome Measures

Primary Outcomes (1)

  • The primary outcome is the variation of the angle of Vertebral Kyphosis or, in the case of asymmetrical fractures, the angle of lateral vertebral inclination between inclusion and one year follow-up examination

    1 year

Secondary Outcomes (11)

  • Pain evaluation using a visual analogic scale

    J-20 à J-7 / J6 / J45 /J90 /J180 / J360

  • questionnaire for back pain evaluation : Eifel

    J-20 à J-7 / J6 / J45 /J90 /J180 / J360

  • Quality of life evaluation (SF 12).

    J-20 à J-7 / J6 / J45 /J90 /J180 / J360

  • Analgesics intake according to the WHO classification (Classes 1, 2 and 3).

    J-20 à J-7 / J6 / J45 /J90 /J180 / J360

  • Regional spine Kyphosis angle and global thoracic and lumbar Kyphosis angle

    J-20 à J-7 / J6 / J45 /J90 /J180 / J360

  • +6 more secondary outcomes

Study Arms (2)

1

OTHER

conventional orthopedic brace with antalgic treatment

Other: orthopedic brace

2

OTHER

balloon kyphoplasty introduction of balloon into the vertebral body, inflation of the balloon which creates a cavity, then balloon is deflated and removed , then introduction of the cement into the cavity.

Device: balloon kyphoplasty

Interventions

antalgic drugs and orthopedic brace

Also known as: böhler brace
1

introduction of balloon into the vertebral body, inflation of the balloon which creates a cavity, then balloon is deflated and removed , then introduction of the cement into the cavity.

2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Preliminary clinical exam (the anesthetist must have provided his approval for the surgical procedure)
  • Patient must have signed the consent form (ZELEN Randomization protocol)
  • Male or Female, 18 years or older;
  • Thoracic vertebral Kyphosis \>15° or Lumbar vertebral Kyphosis \> 10°, or Lateral angulation \> 10°.
  • Pain with VAS ≥ 5.
  • The benign nature of the vertebral fracture has to be confirmed by the results of the biopsy performed during balloon kyphoplasty, or by one year follow-up in the Böhler Brace Group.
  • Technical feasibility of a balloon kyphoplasty and Bohler bracing within 7 days after patient randomization.

You may not qualify if:

  • Vertebral fracture of more than 10 day duration
  • Vertebral fracture not located between T11 and L5
  • Vertebral fracture type different from types A1, A2 and A3.1 according to MAGERL classification.
  • Thoracic vertebral Kyphosis ≤ 15° or Lumbar vertebral Kyphosis ≤ 10°, or Lateral angulation ≤ 10°.
  • Osteoporotic vertebral fracture
  • Association to other post traumatic fractures.
  • Neurological signs or symptoms related to the vertebral fracture
  • History of spine fracture, kyphoplasty, spine surgery at thoracic or lumbar levels with low back pain.
  • History of surgery is not per sue a contraindication if there is no residual low back pain. However, in case of spinal fusion history, the fracture to be treated should be at minimum of two disc space from the most proximal or distal end of the fusion.
  • Current infection
  • Impossibility to perform the percutaneous approach of the vertebra to treat.
  • Known allergy to the contrast product used during the Kyphoplasty procedure or to any of the cement components
  • Reduction by more than 50% of the anteroposterior width of the bony spinal canal due to the vertebral fracture to treat.
  • Vertebral fracture with loss of 90% or more of the vertebral body height
  • Malignant and traumatic vertebral fractures
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital LARIBOISIERE Service de Radiologie Ostéo-Articulaire

Paris, 75010, France

Location

MeSH Terms

Conditions

Spinal Fractures

Interventions

Kyphoplasty

Condition Hierarchy (Ancestors)

Spinal InjuriesBack InjuriesWounds and InjuriesFractures, Bone

Intervention Hierarchy (Ancestors)

VertebroplastyCementoplastyOrthopedic ProceduresTherapeuticsSurgical Procedures, Operative

Study Officials

  • Jean-Denis LAREDO, MD, Pr

    AP-HP Assistance Publique- Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 8, 2008

First Posted

September 9, 2008

Study Start

December 1, 2007

Primary Completion

June 1, 2012

Study Completion

June 1, 2012

Last Updated

December 16, 2014

Record last verified: 2012-11

Locations